Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07199374 · ClinicalTrials.gov registry record · NA
PARCA (a Digital Tool) to Improve Justice and Health
A NA study of Behavioral Addiction, sponsored by George Mason University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT07199374: Recruiting NA study of Behavioral Addiction, sponsored by George Mason University.
NCT07199374 is a NA study of Behavioral Addiction that is actively recruiting participants, run by George Mason University. The registered enrollment target is 50 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07199374, a NA study of Behavioral Addiction, is actively recruiting participants, sponsored by George Mason University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to conduct surveys and interviews aimed to gain a better understanding of ways to improve the substance use treatment process, connections between clients and officers, and goal selection and achievement for clients using the PARCA app
Conditions Studied
Interventions
- BEHAVIORAL PARCA
Study Locations (2)
Texas
- Travis County Community Services - Austin
- Dallas County Community Supervision - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07199374
The ClinicalTrials.gov registry entry for NCT07199374 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Mason University, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Behavioral Addiction appearing as the primary indexed condition, and to 1 intervention - of which PARCA is the first listed.
NCT07199374 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07199374 about?
NCT07199374 is a clinical study titled "PARCA (a Digital Tool) to Improve Justice and Health". The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to condu...
What is the current status of trial NCT07199374?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-03-01. Estimated completion is 2027-05.
What conditions does trial NCT07199374 study?
This clinical trial studies the following conditions: Behavioral Addiction.
What interventions are being tested in trial NCT07199374?
The interventions under investigation include: PARCA (BEHAVIORAL).
Who is sponsoring clinical trial NCT07199374?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07199374 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.